PurCell Bio
PrivateLast Round
Accelerator
May 22, 2024
Total Funding Raised
$44,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PurCell Bio operates in Healthcare & Life Sciences and is based in Bozeman, Montana. Its latest recorded funding round was an Accelerator round in May 2024.
PurCell Bio is a biotechnology company that develops and manufactures chemically-defined, animal-origin-free cell culture media and supplements designed to replace fetal bovine serum.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PurCell Bio Comparables
Compare PurCell Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Media City Scientific | 92% | |
| InVitria | 81% | |
| Alt Biotech | 78% |
For institutional investors. Book with your work email.
PurCell Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 22, 2024 | ||||
| Grant | Oct 1, 2023 | ||||
| Seed Round | Aug 8, 2022 | ||||
| Grant | May 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PurCell Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Next Frontier Capital | Seed Round |
| Montana Department of Commerce | Grant |
| Jake Jabs College of Business and Entrepreneurship | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1659% MoM.
- May 22, 2024
Received funding from Mansfield Bio-Incubator.
For institutional investors. Book with your work email.
PurCell Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PurCell Bio's valuation, stock price, and market status.
Is PurCell Bio a public or private company?
PurCell Bio is a private company.
What is the current stock price of PurCell Bio?
PurCell Bio is a private company, so its shares have no public market price. Caplight tracks PurCell Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PurCell Bio worth (valuation)?
Valuation information for PurCell Bio is not publicly available.
Can I buy PurCell Bio stock?
PurCell Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PurCell Bio's last funding round?
PurCell Bio's most recent funding round was Accelerator on May 22, 2024.
Who are the main investors in PurCell Bio?
Key investors in PurCell Bio include Next Frontier Capital, Montana Department of Commerce, Jake Jabs College of Business and Entrepreneurship.
Will PurCell Bio IPO soon?
No public IPO plans have been announced for PurCell Bio.
How can I track PurCell Bio secondary market activity?
Caplight tracks bids, offers, and trades in PurCell Bio's shares on secondary markets.